https://www.youtube.com/watch?v=knlqvghkjqa
The actions of Hypera (Hype3) already rose 56% in 2025, but are still cheap, according to the Itaú BBA. The bank raised the target price of the papers to R $ 35 and recommends buywith the perspective that the company enters the Semaglutado generic market (Ozempic).
The projection of analysts is that the papers advance more 26%driven by a revenue gain with new medicines by 2027. The moment of pharmaceutical It was one of the highlights of Money Pickspresented by Juliana Caveiro, reporter for Money Times.
THE Santander also reinforced the recommendation of buy to the Hyperawith new target price of R $ 30.50. The value represents an appreciation of about 10%. For the bank, the company is cheap and presented improvement in profits, with good prospects for the future.
Among the other recommendations of the week, the RD Health (Radl3) can still rise more than 20%, according to the BRADESCO BBI. Analysts recommend buying shares, with target price of R $ 17. The bank sees the company cheap after falling about 35% in the year.
Another company that had the high target price was the Sabesp (SBSP3). THE XP Investments made a light adjustment, from $ 129 to R $ 130 and sustained the recommendation for buy. Analysts see the successful company in the execution of investments and capital allocation.
In the telecommunications sector, the Telefônica Brasil (VIVT3)owner of Aliveis the favorite of investors. According to the Santanderthe company must have higher profits in 2026, with good prospects for dividends. The bank recommends buywith target price of R $ 33.
THE Directional (Dirr3) is also one of the highlights of the week. Shares have already rose 60% in 2025 and continue in the recommendations of Empiricus Research. The house states that the moment is positive for the distribution of dividends, which should excite investors.
The journalist opened more details about analysts’ observations for each action. To stay on top of the recommendations, follow Money Picks on the Money Times on YouTube channel.
Source: Moneytimes
I am an author and journalist with a focus on market news. I have worked for a global news website for the past two years, writing articles on a range of topics relating to the stock market. My work has been published in international publications and I have delivered talks at both academic institutions and business conferences around the world.
